טוען...
Impact of hemoperfusion with polymyxin B added to hemofiltration in patients with endotoxic shock: a case–control study
BACKGROUND: Septic shock is a leading cause of death in critical patients. In patients with gram-negative septic shock, hemoperfusion with polymyxin B aims to remove endotoxins from plasma. We analyzed the clinical and biological response to hemoperfusion in patients with septic shock and acute kidn...
שמור ב:
| הוצא לאור ב: | Ann Intensive Care |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer International Publishing
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6286296/ https://ncbi.nlm.nih.gov/pubmed/30535929 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13613-018-0465-8 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|